Johnson & Johnson Innovation
Overview
JJDC finds transformative ideas and helps them mature into real solutions for today’s patients.
Investment Focus
- Innovative healthcare solutions
- Early-stage companies
- Collaborations with entrepreneurs and startups
- Licensing opportunities
- Integrated healthcare solutions
- Access to early-stage research funding
- Global healthcare impact
Portfolio Companies
Reach Johnson & Johnson Innovation directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Johnson & Johnson Innovation
What sectors does Johnson & Johnson Innovation invest in?
Johnson & Johnson Innovation invests in Healthcare, Digital Health, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Cambridge, Massachusetts, United States. Johnson & Johnson Innovation is listed as a private equity in the ConnectSafely investor database.
What stage does Johnson & Johnson Innovation invest at?
Johnson & Johnson Innovation backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Johnson & Johnson Innovation invest in?
Johnson & Johnson Innovation invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has Johnson & Johnson Innovation invested in?
Johnson & Johnson Innovation's portfolio includes Actelion Pharmaceuticals Ltd., Janssen Pharmaceuticals, Kenvue Inc., Janssen Biotech, Inc., Janssen Research & Development, LLC, Janssen Immunology, Janssen Oncology and Janssen Neuroscience.
Last updated · Source: ConnectSafely investor database
